(Reuters) - Results of a bigger late-stage trial of the drug, which is currently approved to treat colon cancer and head and neck cancer, are not yet available.
The bigger trial, which is testing the drug with a different chemotherapy regime, would form the basis of a marketing application with regulators.
Read more at Reuters.com Hot Stocks News
The bigger trial, which is testing the drug with a different chemotherapy regime, would form the basis of a marketing application with regulators.
Read more at Reuters.com Hot Stocks News
No comments:
Post a Comment